KCM Investment Advisors LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 84.1% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 3,983 shares of the medical equipment provider's stock after purchasing an additional 1,819 shares during the period. KCM Investment Advisors LLC's holdings in Intuitive Surgical were worth $2,079,000 at the end of the most recent reporting period.
Several other large investors have also modified their holdings of the business. Resona Asset Management Co. Ltd. purchased a new stake in shares of Intuitive Surgical during the fourth quarter valued at about $101,613,000. Prudential PLC increased its holdings in shares of Intuitive Surgical by 18.3% during the fourth quarter. Prudential PLC now owns 23,801 shares of the medical equipment provider's stock valued at $12,423,000 after acquiring an additional 3,679 shares in the last quarter. ExodusPoint Capital Management LP increased its holdings in shares of Intuitive Surgical by 1,556.7% during the fourth quarter. ExodusPoint Capital Management LP now owns 65,176 shares of the medical equipment provider's stock valued at $34,019,000 after acquiring an additional 61,242 shares in the last quarter. Grant Private Wealth Management Inc purchased a new position in shares of Intuitive Surgical in the 4th quarter valued at approximately $1,801,000. Finally, Spahn Wealth & Retirement LLC purchased a new stake in Intuitive Surgical during the 4th quarter worth approximately $4,343,000. Institutional investors own 83.64% of the company's stock.
Analysts Set New Price Targets
ISRG has been the subject of a number of research analyst reports. Barclays raised their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a report on Monday, January 27th. Evercore ISI raised their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Jefferies Financial Group boosted their price target on Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Raymond James increased their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an "outperform" rating in a research note on Friday, January 24th. Finally, Citigroup increased their price target on Intuitive Surgical from $640.00 to $711.00 and gave the stock a "buy" rating in a research report on Friday, January 24th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $611.86.
View Our Latest Research Report on Intuitive Surgical
Insider Buying and Selling
In related news, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now owns 2,630 shares in the company, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Robert Desantis sold 11,545 shares of the company's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the transaction, the executive vice president now owns 5,224 shares in the company, valued at $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by insiders.
Intuitive Surgical Trading Down 0.1 %
ISRG stock traded down $0.58 during midday trading on Friday, hitting $488.94. 737,419 shares of the company's stock were exchanged, compared to its average volume of 1,590,199. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The business has a 50-day simple moving average of $534.44 and a two-hundred day simple moving average of $532.30. The stock has a market capitalization of $174.15 billion, a PE ratio of 76.25, a P/E/G ratio of 5.85 and a beta of 1.55.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Articles

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.